v2.3.0.11
Financial Instruments
12 Months Ended
Jun. 26, 2011
Financial Instruments  
Financial Instruments

Note 4: Financial Instruments

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. An asset or liability's level in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by, observable market data for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

 

The following table sets forth the Company's financial assets and liabilities measured at fair value on a recurring basis as of June 26, 2011:

 

    Total     Fair Value Measurement at June 26, 2011  
    Quoted Prices in
Active  Markets for
Identical Assets

(Level 1)
    Significant Other
Observable Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
 
          (In thousands)        

Assets

       

Short-Term Investments

       

Money Market Funds

  $ 1,300,098      $ 1,300,098      $      $   

Municipal Notes and Bonds

    321,339               321,339          

US Treasury and Agencies

    8,496        8,496                 

Government-Sponsored Enterprises

    19,868               19,868          

Foreign Government Bonds

    1,005               1,005          

Corporate Notes and Bonds

    382,432        164,885        217,547          

Mortgage Backed Securities — Residential

    2,633               2,633          

Mortgage Backed Securities — Commercial

    60,729               60,729          
 

 

 

   

 

 

   

 

 

   

 

 

 

Total Short-Term Investments

  $ 2,096,600      $ 1,473,479      $ 623,121      $   

Equities

    7,443        7,443                 

Mutual Funds

    19,467        19,467                 

Derivatives Assets

    1,994               1,994          
 

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,125,504      $ 1,500,389      $ 625,115      $   
 

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities

       

Derivative liabilities

  $ 1,924      $      $ 1,924      $   
 

 

 

   

 

 

   

 

 

   

 

 

 

The amounts in the table above are reported in the consolidated balance sheet as of June 26, 2011 as follows:

 

Reported As:    Total      (Level 1)      (Level 2)      (Level 3)  
     (In thousands)  

Cash Equivalents

   $ 1,301,600       $ 1,300,098       $ 1,502       $   

Short-Term Investments

     630,115         8,496         621,619           

Restricted Cash and Investments

     164,885         164,885                   

Prepaid Expenses and Other Current Assets

     26,910         26,910                   

Other Assets

     1,994                 1,994           
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 2,125,504       $ 1,500,389       $ 625,115       $   
  

 

 

    

 

 

    

 

 

    

 

 

 

Accrued Expenses and Other Current Liabilities

   $ 1,924       $       $ 1,924       $   
  

 

 

    

 

 

    

 

 

    

 

 

 

 

The following table sets forth the Company's financial assets and liabilities measured at fair value on a recurring basis as of June 27, 2010:

 

     Total      Fair Value Measurement at June 27, 2010  
      Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
     Significant Other
Observable Inputs
(Level 2)
     Significant
Unobservable
Inputs

(Level 3)
 
            (In thousands)         

Assets

           

Short-Term Investments

           

Money Market Funds

   $ 470,936       $ 470,936       $       $   

Municipal Notes and Bonds

     103,903                 103,903           

US Treasury and Agencies

     3,447                 3,447           

Government-Sponsored Enterprises

     6,060         6,060                   

Foreign Government Bonds

     1,008                 1,008           

Corporate Notes and Bonds

     289,437         169,723         119,636         78   

Mortgage Backed Securities — Residential

     6,106                 6,106           

Mortgage Backed Securities — Commercial

     42,964                 42,964           
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Short-Term Investments

   $ 923,861       $ 646,719       $ 277,064       $ 78   

Equities

     7,636         7,636                   

Mutual Funds

     18,124         18,124                   

Derivatives Assets

     2,063                 2,063           
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 951,684       $ 672,479       $ 279,127       $ 78   
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Derivative liabilities

   $ 470       $       $ 470       $   
  

 

 

    

 

 

    

 

 

    

 

 

 

The amounts in the table above are reported in the consolidated balance sheet as of June 27, 2010 as follows:

 

Reported As:    Total      (Level 1)      (Level 2)      (Level 3)  
     (In thousands)  

Cash Equivalents

   $ 478,286       $ 477,279       $ 1,007       $   

Short-Term Investments

     280,690         4,555         276,057         78   

Restricted Cash and Investments

     164,885         164,885                   

Prepaid Expenses and Other Current Assets

     2,063                 2,063           

Other Assets

     25,760         25,760                   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 951,684       $ 672,479       $ 279,127       $ 78   
  

 

 

    

 

 

    

 

 

    

 

 

 

Accrued Expenses and Other Current Liabilities

   $ 470       $       $ 470       $   
  

 

 

    

 

 

    

 

 

    

 

 

 

The Company's primary financial instruments include its cash, cash equivalents, short-term investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and capital leases, and foreign currency related derivatives. The estimated fair value of cash, accounts receivable and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of long-term debt, excluding convertible notes, and capital lease obligations approximate their carrying value as the substantial majority of these obligations have interest rates that adjust to market rates on a periodic basis. The estimated fair value of convertible notes approximates their carrying value as interest rates on comparable debt have not changed significantly since issuance of the notes. The fair value of cash equivalents, short-term investments, restricted cash and investments, long-term investments, and foreign currency related derivatives are based on quotes from brokers using market prices for similar instruments.

 

Investments

The following tables summarize the Company's investments (in thousands):

 

    June 26, 2011     June 27, 2010  
    Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Value     Cost     Unrealized
Gain
    Unrealized
(Loss)
    Fair Value  

Cash

  $ 190,903      $      $      $ 190,903      $ 67,830      $      $      $ 67,830   

Fixed Income Money Market Funds

    1,300,098                      1,300,098        470,936                      470,936   

Municipal Notes and Bonds

    319,913        1,510        (84     321,339        102,130        1,784        (11     103,903   

US Treasury and Agencies

    8,462        34               8,496        3,437        10               3,447   

Government-Sponsored Enterprises

    19,864        6        (2     19,868        5,976        84               6,060   

Foreign Government Bonds

    1,004        1               1,005        1,007        1               1,008   

Corporate Notes and Bonds

    380,992        1,498        (58     382,432        287,922        1,608        (93     289,437   

Mortgage Backed Securities — Residential

    2,521        144        (32     2,633        5,825        323        (42     6,106   

Mortgage Backed Securities — Commercial

    60,639        277        (187     60,729        42,765        275        (76     42,964   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Cash and Short-Term Investments

  $ 2,284,396      $ 3,470      $ (363   $ 2,287,503      $ 987,828      $ 4,085      $ (222   $ 991,691   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Publicly Traded Equity Securities

  $ 9,320      $      $ (1,877   $ 7,443      $ 9,471      $      $ (1,835   $ 7,636   

Mutual Funds

    17,975        1,492               19,467        19,043               (919     18,124   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Financial Instruments

  $ 2,311,691      $ 4,962      $ (2,240   $ 2,314,413      $ 1,016,342      $ 4,085      $ (2,976   $ 1,017,451   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

As Reported

               

Cash and Cash Equivalents

  $ 1,492,132      $      $      $ 1,492,132      $ 545,766      $ 1      $      $ 545,767   

Short-Term Investments

    627,008        3,470        (363     630,115        276,828        4,084        (222     280,690   

Restricted Cash and Investments

    165,256                      165,256        165,234                      165,234   

Prepaid Expenses Other Assets

    27,295        1,492        (1,877     26,910        28,514               (2,754     25,760   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total

  $ 2,311,691      $ 4,962      $ (2,240   $ 2,314,413      $ 1,016,342      $ 4,085      $ (2,976   $ 1,017,451   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investments sold are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments. The Company also considers whether changes in the credit ratings of the issuer could impact the assessment of fair value. Net realized gains (losses) on investments included other-than-temporary impairment charges of $0 million, $0.9 million and $0.3 million in fiscal years 2011, 2010 and 2009, respectively. Additionally, realized gains/(losses) from sales of investments were approximately $0.7 million and $(0.3) million in fiscal year 2011, $0.8 million and $(0.2) million in fiscal year 2010, $2.2 million and $(1.9) million in fiscal year 2009, respectively.

 

The following is an analysis of the Company's fixed income securities in unrealized loss positions as of June 26, 2011 (in thousands):

 

     June 26, 2011  
     UNREALIZED LOSSES
LESS THAN 12 MONTHS
    UNREALIZED LOSSES
12 MONTHS OR GREATER
    TOTAL  
         Fair Value          Unrealized     Fair Value      Unrealized     Fair Value      Unrealized  

Fixed Income Securities

               

Municipal Notes and Bonds

   $ 60,311       $ (84   $       $      $ 60,311       $ (84

Government-Sponsored Enterprises

     9,995         (2                    9,995         (2

Corporate Notes and Bonds

     43,383         (58                    43,383         (58

Mortgage Backed Securities — Residential

                    273         (32     273         (32

Mortgage Backed Securities — Commercial

     32,539         (187                    32,539         (187
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Total Fixed Income

   $ 146,228       $ (331   $ 273       $ (32   $ 146,501       $ (363
  

 

 

    

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

The amortized cost and fair value of cash equivalents and short-term investments and restricted cash and investments with contractual maturities are as follows:

 

     June 26, 2011      June 27, 2010  
     Cost      Estimated
Fair Value
     Cost      Estimated
Fair Value
 
     (in thousands)  

Due in less than one year

   $ 1,606,390       $ 1,606,925       $ 723,143       $ 723,707   

Due in more than one year

     487,103         489,675         196,855         200,154   
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 2,093,493       $ 2,096,600       $ 919,998       $ 923,861   
  

 

 

    

 

 

    

 

 

    

 

 

 

Management has the ability, if necessary, to liquidate any of its investments in order to meet the Company's liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than one year from the date of purchase nonetheless are classified as short-term on the accompanying consolidated balance sheets.

Derivative Instruments and Hedging

The Company carries derivative financial instruments ("derivatives") on its consolidated balance sheets at their fair values. The Company enters into foreign exchange forward contracts with financial institutions with the primary objective of reducing volatility of earnings and cash flows related to foreign currency exchange rate fluctuations. The counterparties to these foreign exchange forward contracts are creditworthy multinational financial institutions; therefore, we do not consider the risk of counterparty nonperformance to be material.

Cash Flow Hedges

The Company's policy is to attempt to minimize short-term business exposure to foreign currency exchange rate fluctuations using an effective and efficient method to eliminate or reduce such exposures. In the normal course of business, the Company's financial position is routinely subjected to market risk associated with foreign currency exchange rate fluctuations. To protect against a reduction in value of Japanese yen-denominated revenues and Euro-denominated expenses, the Company has instituted a foreign currency cash flow hedging program. The Company enters into foreign exchange forward contracts that generally expire within 12 months and no later than 24 months. These foreign exchange forward contracts are designated as cash flow hedges and are carried on the Company's balance sheet at fair value with the effective portion of the contracts' gains or losses included in accumulated other comprehensive income (loss) and subsequently recognized in revenue in the same period the hedged revenue is recognized.

At inception and at each quarter end, hedges are tested prospectively and retrospectively for effectiveness using regression analysis. Changes in the fair value of foreign exchange forward contracts due to changes in time value are excluded from the assessment of effectiveness and are recognized in revenue in the current period. The change in time value related to these contracts was not material for all reported periods. To qualify for hedge accounting, the hedge relationship must meet criteria relating both to the derivative instrument and the hedged item. These criteria include identification of the hedging instrument, the hedged item, the nature of the risk being hedged and how the hedging instrument's effectiveness in offsetting the exposure to changes in the hedged item's fair value or cash flows will be measured. There were no gains or losses during the twelve months ended June 26, 2011 or June 27, 2010 associated with ineffectiveness or forecasted transactions that failed to occur. There were $4.0 million of deferred net losses associated with ineffectiveness related to forecasted transactions that were no longer considered probable of occurring and were recognized in "Other income (expense), net" in the Company's consolidated statements of operations during twelve months ended June 28, 2009.

To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge and the hedges must be tested to demonstrate an expectation of providing highly effective offsetting changes to future cash flows on hedged transactions. When derivative instruments are designated and qualify as effective cash flow hedges, the Company is able to defer effective changes in the fair value of the hedging instrument within accumulated other comprehensive income (loss) until the hedged exposure is realized. Consequently, with the exception of excluded time value and hedge ineffectiveness recognized, the Company's results of operations are not subject to fluctuation as a result of changes in the fair value of the derivative instruments. If hedges are not highly effective or if the Company does not believe that the underlying hedged forecasted transactions will occur, the Company may not be able to account for its derivative instruments as cash flow hedges. If this were to occur, future changes in the fair values of the Company's derivative instruments would be recognized in earnings. Additionally, related amounts previously recorded in "Other comprehensive income" would be reclassified to income immediately. At June 26, 2011, the Company had gains of $0.6 million accumulated in Other Comprehensive Income, which it expects to reclassify from Other Comprehensive Income into earnings over the next 12 months.

Balance Sheet Hedges

The Company also enters into foreign exchange forward contracts to hedge the effects of foreign currency fluctuations associated with foreign currency denominated monetary assets and liabilities, primarily intercompany receivables and payables. These foreign exchange forward contracts are not designated for hedge accounting treatment. Therefore, the change in fair value of these derivatives is recorded as a component of other income (expense) and offsets the change in fair value of the foreign currency denominated assets and liabilities, recorded in other income (expense).

 

As of June 26, 2011, the Company had the following outstanding foreign currency forward contracts that were entered into to hedge forecasted revenues and purchases:

 

     Derivatives Designated as
Hedging Instruments:
     Derivatives Not Designated as
Hedging Instruments:
 
     (in thousands)  

Foreign Currency Forward Contracts

     

Sell JPY

   $  107,912       $ 62,012   

Buy CHF

             257,588   

Buy EUR

     103,590         41,802   

Buy TWD

             83,368   
  

 

 

    

 

 

 
   $ 211,502       $  444,770   
  

 

 

    

 

 

 

The fair value of derivatives instruments in the Company's consolidated balance sheet as of June 26, 2011 was as follows:

 

     Fair Value of Derivative Instruments  
     Asset Derivatives      Liability Derivatives  
     Balance Sheet
Location
   Fair Value      Balance Sheet
Location
   Fair Value  
     (in thousands)  

Derivatives designated as hedging instruments:

           

Foreign exchange forward contracts

   Prepaid expense
and other assets
   $ 1,881       Accrued liabilities    $ (1,142

Derivatives not designated as hedging instruments:

           

Foreign exchange forward contracts

   Prepaid expense
and other assets
     113       Accrued liabilities      (782
     

 

 

       

 

 

 

Total derivatives

      $ 1,994          $ (1,924
     

 

 

       

 

 

 

The fair value of derivatives instruments in the Company's consolidated balance sheet as of June 27, 2010 was as follows:

 

     Fair Value of Derivative Instruments  
     Asset Derivatives      Liability Derivatives  
     Balance Sheet
Location
   Fair Value      Balance Sheet
Location
   Fair Value  
     (in thousands)  

Derivatives designated as hedging instruments:

           

Foreign exchange forward contracts

   Prepaid expense
and other assets
   $ 30       Accrued liabilities    $ (52

Derivatives not designated as hedging instruments:

           

Foreign exchange forward contracts

   Prepaid expense
and other assets
     2,033       Accrued liabilities      (418
     

 

 

       

 

 

 

Total derivatives

      $ 2,063          $ (470
     

 

 

       

 

 

 

 

The effect of derivative instruments designated as cash flow hedges on the Company's consolidated statements of operations for the twelve months ended June 26, 2011 and June 27, 2010 was as follows:

 

The effect of derivative instruments not designated as cash flow hedges on the Company's consolidated statement of operations for the twelve months ended June 26, 2011 and June 27, 2010 was as follows:

 

 

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash equivalents, short term investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit in major financial institutions in various countries throughout the world. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company's cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances.

The Company's available-for-sale securities must have a minimum rating of A2 / A at the time of original purchase, as rated by two of the following three rating agencies: Moody's, Standard & Poor's (S&P), or Fitch. The Company's policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on the foreign currency forward contracts that are used to mitigate the effect of exchange rate changes and on contracts related to structured share repurchase agreements. These counterparties are large international financial institutions and to date, no such counterparty has failed to meet its financial obligations to the Company.

As of June 26, 2011, three customers accounted for approximately 17%, 14%, and 10% of accounts receivable. As of June 27, 2010, two customers accounted for approximately 24% and 22 % of accounts receivable.

Credit risk evaluations, including trade references, bank references and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers' financial statements and payment performance. In general, the Company does not require collateral on sales.